Cargando…

Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives

Gestational diabetes mellitus (GDM) is defined as any degree of carbohydrate intolerance, with onset or first recognition during second or third trimester of gestation. It is estimated that approximately 7% of all pregnancies are complicated by GDM and that its prevalence is rising all over the worl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarino, Elisa, Delli Poggi, Chiara, Grieco, Giuseppina Emanuela, Cenci, Valeria, Ceccarelli, Elena, Crisci, Isabella, Sebastiani, Guido, Dotta, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924999/ https://www.ncbi.nlm.nih.gov/pubmed/29849620 http://dx.doi.org/10.1155/2018/6380463

Ejemplares similares

Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p
por: Sebastiani, Guido, et al.
Publicado: (2017)

Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis
por: Filardi, Tiziana, et al.
Publicado: (2022)

Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism
por: Grieco, Giuseppina E., et al.
Publicado: (2018)

MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes
por: Nigi, Laura, et al.
Publicado: (2018)

Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes
por: Grieco, Giuseppina Emanuela, et al.
Publicado: (2019)

Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study
por: Formichi, Caterina, et al.
Publicado: (2021)

The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection
por: Grieco, Giuseppina Emanuela, et al.
Publicado: (2021)

Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases
por: Formichi, Caterina, et al.
Publicado: (2021)

Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples
por: Grieco, Giuseppina E., et al.
Publicado: (2021)

MicroRNA Expression Analysis of In Vitro Dedifferentiated Human Pancreatic Islet Cells Reveals the Activation of the Pluripotency-Related MicroRNA Cluster miR-302s
por: Sebastiani, Guido, et al.
Publicado: (2018)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools
por: Grieco, Giuseppina Emanuela, et al.
Publicado: (2021)

Characterization of Maternal Circulating MicroRNAs in Obese Pregnancies and Gestational Diabetes Mellitus
por: Serati, Anaïs, et al.
Publicado: (2023)

MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes
por: Ventriglia, Giuliana, et al.
Publicado: (2015)

The Temporal Profile of Circulating miRNAs during Gestation in Overweight and Obese Women with or without Gestational Diabetes Mellitus
por: Sørensen, Anja Elaine, et al.
Publicado: (2022)

Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus
por: Jamalpour, Sajad, et al.
Publicado: (2022)

Circulating Noncoding RNAs as Candidate Biomarkers of Endocrine and Metabolic Diseases
por: Sebastiani, Guido, et al.
Publicado: (2018)

Gestational diabetes mellitus 2018 guidelines: An update
por: Mishra, Surabhi, et al.
Publicado: (2018)

A Clinical Update on Gestational Diabetes Mellitus
por: Sweeting, Arianne, et al.
Publicado: (2022)

Circulating MicroRNAs in Elderly Type 2 Diabetic Patients
por: Catanzaro, Giuseppina, et al.
Publicado: (2018)

Author Correction: Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus
por: Jamalpour, Sajad, et al.
Publicado: (2023)

Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
por: Burlina, S., et al.
Publicado: (2016)

An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus
por: Vasile, Flavia Cristina, et al.
Publicado: (2021)

Gestational Diabetes Mellitus and Small-for-Gestational-Age: An Insight into the Placental Molecular Biomarkers
por: Giommi, Christian, et al.
Publicado: (2023)

MicroRNAs: An Update of Applications in Forensic Science
por: Rocchi, Anna, et al.
Publicado: (2020)

Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
por: Trebotic, Lana Kosi, et al.
Publicado: (2015)

Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus
por: Eschler, Deirdre Cocks, et al.
Publicado: (2018)

A Big Role for microRNAs in Gestational Diabetes Mellitus
por: Masete, Matladi, et al.
Publicado: (2022)

An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review
por: Minschart, Caro, et al.
Publicado: (2021)

MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells
por: Grieco, Fabio Arturo, et al.
Publicado: (2017)

MiRNAs in Gestational Diabetes Mellitus: Potential Mechanisms and Clinical Applications
por: Liu, Zhao-Nan, et al.
Publicado: (2021)

miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus
por: Juchnicka, Ilona, et al.
Publicado: (2022)

MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus
por: Yang, Xiyao, et al.
Publicado: (2022)

MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema
por: Grieco, Giuseppina Emanuela, et al.
Publicado: (2020)

A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes
por: Sassi, Gabriele, et al.
Publicado: (2023)

Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
por: Nigi, Laura, et al.
Publicado: (2020)

Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors
por: Nigi, Laura, et al.
Publicado: (2022)

Association of circulating CEACAM1 levels and insulin sensitivity in gestational diabetes mellitus
por: Wu, Yiming, et al.
Publicado: (2020)

The Variants in ADIPOQ are Associated with Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus
por: Tangjittipokin, Watip, et al.
Publicado: (2023)

Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation
por: Grieco, Giuseppina E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkppd50d2aoc6hpdsv51ff0hsk